Vaneet K. Sandhu, MD, MS, RhMSUS, is a rheumatologist and clinical development leader specializing in autoimmunity. She serves as Vice President of Clinical Development, Autoimmunity at Fate Therapeutics, Inc., where she leads the development of innovative iPSC-derived cellular therapy programs. Her clinical focus includes systemic autoimmune rheumatic disease, inflammatory arthritis, and musculoskeletal and metabolic bone care. Her research interests center on cellular immunotherapy for autoimmune disease, biomarker development and patient registries, and health disparities and medical education in rheumatology. Dr. Sandhu previously held academic and clinical leadership roles at Loma Linda University Health, the University of California, Riverside, and Riverside University Health System, including Associate Professor of Medicine, Director of the Lupus Center, Director of Rheumatology Clinics, and rheumatology fellowship program leadership. Her achievements include serving as principal investigator on a major California Institute for Regenerative Medicine-supported clinical program, advising Lupus LA as a Medical Advisory Board member, and leading nationally through the American College of Rheumatology as co-chair of the Women in Rheumatology Taskforce and a member of key communications and workforce committees. Dr. Sandhu earned her MBBS from Dayanand Medical College and Hospital in India, completed her Internal Medicine residency at Loma Linda University Health, and her Rheumatology fellowship at Cedars-Sinai Medical Center. She also holds a Master of Science in Academic Medicine from the University of Missouri.
Clinical Development
Medical School
2002 – 2008
Residency
2008 – 2013
Fellowship
2013 – 2015